A safety study of nivolumab in patients with recurrent and/or metastatic platinum-refractory squamous cell carcinoma of the head and neck (R/M SCCHN): Interim analysis on 199 patients—The TOPNIVO study on behalf of the GORTEC and the Unicancer Head & Neck Group.

Caroline Even, Amaury Daste, Esma Saada-Bouzid, Gautier Lefebvre, Jerome Fayette, Sylvie Zanetta, Marie-Christine Kaminsky, Didier Cupissol, Alain Prevost, Elodie Vauleon, Alison Claire Johnson, Sebastien Salas, Frederic Rolland, Miruna Timar David, Isabelle Jallut, Jessy Delaye, Jean Bourhis, Joel Guigay, Matthieu Texier, Anne Auperin

J Clin Oncol 37, 2019 (suppl; abstr 6032)

TPExtreme randomized trial: TPEx versus Extreme regimen in 1st line recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC)

Joel Guigay, Jerome Fayette, Ricard Mesia, Cedrik Lafond, Esma Saada-Bouzid, Lionnel Geoffrois, Laurent Martin, Didier Cupissol, Olivier Capitain, Helene Castanie, Damien Vansteene, Philippe Schafhausen, Catherine Dubos Arvis, Caroline Even, Christian Sire, Melissa Delhommeau, Cecile Michel, Jean Bourhis, Ulrich Keilholz, Anne Auperin

J Clin Oncol 37, 2019 (suppl; abstr 6002)